Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni China
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
    • 简体中文
Menu Close

Daily Archives: 2020-11-10

  1. Home>
  2. 2020>
  3. November>
  4. 10
Read more about the article Beroni Group Launches a New Probiotics Health Product in China
Beilemei

Beroni Group Launches a New Probiotics Health Product in China

  • Post author:tnt
  • Post published:2020-11-10
  • Post category:2020
  • Post comments:0 Comments

NEW YORK and SYDNEY, November 10, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development,…

Continue ReadingBeroni Group Launches a New Probiotics Health Product in China
Read more about the article Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020
Certificate

Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020

  • Post author:tnt
  • Post published:2020-11-10
  • Post category:2020
  • Post comments:0 Comments

NEW YORK and SYDNEY, November 9, 2020 - Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise announced today that the Company has been…

Continue ReadingBeroni Group Named as a Top Infection Control Solutions Company in APAC for 2020

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)

What’s New

  • Wish You Happy New Year!
  • Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project
  • Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association
  • Successful Conclusion to the First “Industry, University Research and Application, Innovative Medicine” Summit Forum and the Establishment of Tianjin Biomedical Discipline Innovation Consortium
  • Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu